| TP53 mutations in human cancers: origins, consequences, and clinical use M Olivier, M Hollstein, P Hainaut Cold Spring Harbor perspectives in biology 2 (1), a001008, 2010 | 2312 | 2010 |
| Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 database A Petitjean, E Mathe, S Kato, C Ishioka, SV Tavtigian, P Hainaut, M Olivier Human mutation 28 (6), 622-629, 2007 | 2010 | 2007 |
| The IARC TP53 database: new online mutation analysis and recommendations to users M Olivier, R Eeles, M Hollstein, MA Khan, CC Harris, P Hainaut Human mutation 19 (6), 607-614, 2002 | 1524 | 2002 |
| Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers GP Pfeifer, MF Denissenko, M Olivier, N Tretyakova, SS Hecht, P Hainaut Oncogene 21 (48), 7435-7451, 2002 | 1375 | 2002 |
| TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes A Petitjean, MIW Achatz, AL Borresen-Dale, P Hainaut, M Olivier Oncogene 26 (15), 2157-2165, 2007 | 1114 | 2007 |
| TP53 Variations in Human Cancers: New Lessons from the IARC TP53 Database and Genomics Data L Bouaoun, D Sonkin, M Ardin, M Hollstein, G Byrnes, J Zavadil, M Olivier Human mutation 37 (9), 865-876, 2016 | 745 | 2016 |
| The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer. M Olivier, A Langer√∏ d, P Carrieri, J Bergh, S Klaar, J Eyfjord, ... Clinical cancer research: an official journal of the American Association …, 2006 | 691 | 2006 |
| Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype M Olivier, DE Goldgar, N Sodha, H Ohgaki, P Kleihues, P Hainaut, ... Cancer research 63 (20), 6643-6650, 2003 | 653 | 2003 |
| Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods E Mathe, M Olivier, S Kato, C Ishioka, P Hainaut, SV Tavtigian Nucleic acids research 34 (5), 1317-1325, 2006 | 395 | 2006 |
| TP53 mutation spectra and load: a tool for generating hypotheses on the etiology of cancer. M Olivier, SP Hussain, C Caron de Fromentel, P Hainaut, CC Harris IARC scientific publications, 247-270, 2004 | 324 | 2004 |
| Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors J George, V Walter, M Peifer, LB Alexandrov, D Seidel, F Leenders, ... Nature communications 9 (1), 1048, 2018 | 285 | 2018 |
| Noninvasive diagnosis of actionable mutations by deep sequencing of circulating free DNA in lung cancer from never-smokers: a proof-of-concept study from BioCAST/IFCT-1002 S Couraud, F Vaca-Paniagua, S Villar, J Oliver, T Schuster, H Blanché, ... Clinical Cancer Research 20 (17), 4613-4624, 2014 | 264 | 2014 |
| Sarcomas in TP53 germline mutation carriers: A review of the IARC TP53 database S Ognjanovic, M Olivier, TL Bergemann, P Hainaut Cancer 118 (5), 1387-1396, 2012 | 246 | 2012 |
| Recent advances in p53 research: an interdisciplinary perspective M Olivier, A Petitjean, V Marcel, A Petre, M Mounawar, A Plymoth, ... Cancer gene therapy 16 (1), 1-12, 2009 | 243 | 2009 |
| The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families MIW Achatz, M Olivier, F Le Calvez, G Martel-Planche, A Lopes, BM Rossi, ... Cancer letters 245 (1-2), 96-102, 2007 | 227 | 2007 |
| Biological functions of p53 isoforms through evolution: lessons from animal and cellular models V Marcel, ML Dichtel-Danjoy, C Sagne, H Hafsi, D Ma, S Ortiz-Cuaran, ... Cell Death & Differentiation 18 (12), 1815-1824, 2011 | 220 | 2011 |
| Understanding wild-type and mutant p53 activities in human cancer: new landmarks on the way to targeted therapies I Goldstein, V Marcel, M Olivier, M Oren, V Rotter, P Hainaut Cancer gene therapy 18 (1), 2-11, 2011 | 218 | 2011 |
| Identification of circulating tumor DNA for the early detection of small-cell lung cancer L Fernandez-Cuesta, S Perdomo, PH Avogbe, N Leblay, TM Delhomme, ... EBioMedicine 10, 117-123, 2016 | 200 | 2016 |
| Integrating mutation data and structural analysis of the TP53 tumor‐suppressor protein ACR Martin, AM Facchiano, AL Cuff, T Hernandez‐Boussard, M Olivier, ... Human mutation 19 (2), 149-164, 2002 | 171 | 2002 |
| Detailed haplotype analysis at the TP53 locus in p.R337H mutation carriers in the population of Southern Brazil: evidence for a founder effect S Garritano, F Gemignani, EI Palmero, M Olivier, G Martel‐Planche, ... Human mutation 31 (2), 143-150, 2010 | 164 | 2010 |
